Induction of p21 (CIP1/WAF1/SID1) by estradiol in a breast epithelial cell line transfected with the recombinant estrogen receptor gene: A possible mechanism for a negative regulatory role of estradiol

Breast Cancer Research and Treatment

Volumn 47, Issue 2, 1998, Pages 181-193

  Thomas, T J ^a,b   Faaland, Carol A ^b   Adhikarakunnathu, Sreedevi ^b   Watkins, Linda F ^c   Thomas, Thresia ^b  

^a RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c KARMANOS CANCER INSTITUTE   (United States)

Author keywords

Estradiol; p21; Recombinant estrogen receptor

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; ESTRADIOL; ESTROGEN RECEPTOR; MESSENGER RNA; N BUTYL 11 (3,17BETA DIHYDROXYESTRA 1,3,5(10) TRIEN 7ALPHA YL) N METHYLUNDECANAMIDE; PROTEIN P21;

ARTICLE; BREAST EPITHELIUM; CELL CYCLE; CELL GROWTH; CELL LINE; CONTROLLED STUDY; DNA SYNTHESIS; EPITHELIUM CELL; FLOW CYTOMETRY; GENE INDUCTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NORTHERN BLOTTING; PRIORITY JOURNAL; REGULATORY MECHANISM;

BREAST; BREAST NEOPLASMS; CELL DIVISION; CELL LINE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; EPITHELIAL CELLS; ESTRADIOL; FEMALE; HUMANS; POLYUNSATURATED ALKAMIDES; RECEPTORS, ESTROGEN; RNA, MESSENGER; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031973862     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005925931215     Document Type: Article

References (75)

1. Beato M: Gene regulation by steroid hormones. Cell 56: 335-344, 1989
2. Mitchell PJ, Tjian R: Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. Science 245: 371-378, 1989
3. Evans RM: The steroid and thyroid hormone receptor superfamily. Science 240: 889-895, 1988
4. Henderson BE, Ross R, Bernstein L: Estrogens as a cause of human cancer: the Richard and Hinda Rosenthal Foundation Award lecture. Cancer Res 48: 246-253, 1988
5. Clarke R, Dickson RB, Lippman ME: Hormonal aspects of breast cancer: Growth factors, drugs and stromal interactions. Crit Rev Oncology-Hemat 12: 1-23, 1992
6. Jordan VC: The strategic use of antiestrogens to control the development and growth of breast cancer. Cancer 70: 977-982, 1992
7. Wakeling AE: The future of new pure antiestrogens in clinical breast cancer. Breast Cancer Res Treat 25: 1-9, 1993
8. Tsai M-J, O'Malley BW: Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem 63: 451-486, 1994
9. Wahli W, Martinez E: Superfamily of nuclear receptors: positive and negative regulators of gene expression. FASEB J 5: 2243-2249, 1991
10. van der Burg B, Selm-Miltenburg AJP, de Laat SW, van Zoelen EJJ: Direct effects of estrogen on c-fos and c-myc protooncogene expression and cellular proliferation in human breast cancer cells. Mol Cell Endocrinol 64: 223-228, 1989
11. Dubik D, Shiu RP: Mechanism of estrogen activation of c-myc oncogene expression. Oncogene 7: 1587-1594, 1992
12. Thomas TJ, Faaland CA, Gallo MA, Thomas T: Suppression of c-myc oncogene expression by a polyamine-complexed triplex forming oligonucleotide in estrogen-responsive MCF-7 breast cancer cells. Nucl Acids Res 23: 3594-3599, 1995
13. Thomas T, Thomas TJ: Estradiol control of ornithine decarboxylase mRNA, enzyme activity, and polyamine levels in MCF-7 breast cancer cells: Therapeutic implications. Breast Cancer Res Treat 29: 189-201, 1993
14. Nunez A-M, Berry M, Imler J-L, Chambon P: The 5′-flanking region of the PS2 gene contains a complex enhancer region responsive to oestrogen, epidermal growth factor, a tumor promoter (TPA), the c-Ha-ras oncoprotein and the c-jun protein. EMBO J 8: 823-829, 1989
15. Musgrove EA, Hamilton JA, Lee CS, Sweeny KJ, Watts CKW, Sutherland RL: Growth factor, steroid and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression. Mol Cell Biol 13: 3577-3587, 1993
16. Garcia M, Derocq D, Freiss G, Rochefort H: Activation of estrogen receptor transfected into a receptor-negative breast cancer cell line decrease the metastatic and invasive potential of the cells. Proc Natl Acad Sci USA 89: 11538-11542, 1992
17. Zajchowski DA, Sager R, Webster L: Estrogen inhibits the growth of estrogen receptor-negative, but not estrogen receptor-positive, human mammary epithelial cells expressing a recombinant estrogen receptor. Cancer Res 53: 5004-5011, 1993
18. Jiang S-Y, Jordan VC: Growth regulation of estrogen receptor-negative breast cancer cells transfected with complementary DNAs for estrogen receptor. J Natl Cancer Inst 84: 580-591, 1992
19. Ray A, Prefontaine K, Ray P: Down-modulation of interleukin-6 gene expression by 17β-estradiol in the absence of high affinity binding by the estrogen receptor. J Biol Chem 269: 12940-12946, 1994
20. Kushner PJ, Hort E, Shine J, Baxter JD, Greene GL: Construction of cell lines that express high levels of the human estrogen receptor that are killed by estrogens. Mol Endocrinol 4: 1465-1473, 1990
21. Watkins LF, Pilot MF, Brooks S, Christman JC, Kral L: Breast epithelial cells transfected with either mutated or wild-type recombinant estrogen receptor respond to 17β-estradiol in the same manner. 1996, submitted
22. Revillion F, Lassalle B, Vandewale B, Lefebvre J: Cell kinetics of estradiol stimulated long-term phenol red withdrawn cultured breast cancer cells. Anticancer Res 10: 1067-1070, 1990
23. Lykkesfeldt AE, Larsen JK, Christensen IJ: Cell cycle analysis of estrogen stimulation and antiestrogen inhibition of growth of the human breast cancer cell line. Breast Cancer Res Treat 7: S83-90, 1986
24. Musgrove EA, Wakeling AE, Sutherland RL: Points of action of estrogen antagonists and a calmodulin antagonist within the MCF-7 human breast cancer cell cycle. Cancer Res 49: 2398-2404, 1989
25. Leung BS, Potter AH: Mode of action of estrogen on cell proliferative kinetics in CAMA-1 cells. I. Effects of serum and estrogen. Cancer Investigation 5: 187-194, 1987
26. Thomas T, Thomas TJ: Regulation of cyclin B1 by estradiol and polyamines in MCF-7 breast cancer cells. Cancer Res 54: 1077-1084, 1994
27. Norbury C, Nurse P: Animal cell cycles and their control. Annu Rev Biochem 61: 441-470, 1992
28. Hunter T, Pines J: Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell 79: 573-582, 1994
29. Steel M: Cyclins and cancer: wheels within wheels. Lancet 343: 931-932, 1994
30. Hunter T: Braking the cycle. Cell 75: 839-841, 1993
31. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B: WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825, 1993
32. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ: The p21 cdk-interacting protein cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816, 1993
33. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D: p21 is a universal inhibitor of cyclin kinases. Nature 366: 701-703, 1993
34. Noda A, Ning Y, Venable SF, Pereira-Smith OM, Smith JR: Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 211: 90-98, 1994
35. Keyomarsi K, Pardee A: Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc Natl Acad Sci USA 90: 1112-1116, 1993
36. Keyomarsi K, O'Leary N, Molnar G, Lees E, Fingert HJ, Pardee AB: Cyclin E, a potential prognostic marker for breast cancer. Cancer Res 54: 380-385, 1994
37. Wang TC, Cardiff RC, Zukerberg L, Lees E, Arnold A, Schmidt EV: Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369: 669-671, 1994
38. Musgrove EA, Lee CSL, Buckley MF, Sutherland RL: Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle. Proc Natl Acad Sci USA 91: 8022-8026, 1994
39. Zhang MY, Thomas TJ, Thomas T: Estradiol enhances the steady state level of cyclin D1 mRNA in MCF-7 breast cancer cells. Program and Abstracts of the 74th Annual Meeting of the Endocrine Society p. 130, 1993
40. Altucci L, Addeo R, Cicatiello L, Dauvois S, Parker MG, Truss M, Beato M, Sica V, Besciani F. Weisz A: 17β-Estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cells. Oncogene 12: 2315-2324, 1996
41. Zhang H, Xiong Y, Death D: Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes. Mol Biol Cell 4: 897-906, 1993
42. El-Deiry WS, Harper JW, O'Conner PM, Velculescu VE, Canman CE, Jackman J, Pietenpol JA, Burrell M, Hill DE, Wang Y, Wiman KG, Mercer WE, Kastan MB, Kohn KW, Elledge SJ, Kinazler KW, Vogelstein B: WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 54: 1169-1174, 1994
43. Michieli P, Chedid M, Lin D, Pierce JH, Mercer WE, Givol D: Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res 54: 3391-3395, 1994
44. Parker SB, Eichele G, Zhang P, Rawls A, Sands AT, Bradley A, Olson EN, Harper JW, Elledge SJ: p53-independent expression of p21/Cip1 in muscle and other terminally differentiating cells. Science 267: 1024-1027, 1995
45. Jiang H, Lin J, Su ZZ, Collart FR, Huberman E, Fisher PB: Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene 9: 3397-3406, 1994
46. Zhang H, Hannon GJ, Beach D: p21-containing cyclin kinases exist in both active and inactive states. Genes Dev 8: 1750-1758, 1994
47. Waga S, Hannon GJ, Beach D, Stillman B: The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369: 574-578, 1994
48. Flores-Rozas H, Kelman Z, Dean FB, Pan Z-Q, Harper JW, Elledge SJ, O'Donnell M, Hurwitz J: CdK-interacting protein 1 directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalysed by the DNA polymerase δ holoenzyme. Proc Natl Acad Sci 91: 8655-8659, 1994
49. Soule HD, Maloney TM, Wolman SR, Peterson WD Jr. Brenz R, McGrath CM, Russo J, Pauley RJ, Jones RF, Brooks SC: Isolation and characterization of a spontaneously immortalized human breast cell line, MCF-10. Cancer Res 50: 6075-6086, 1990
50. Tora L, Mullick A, Metzger D, Ponglikitmongkol M, Park I, Chambon P: The cloned human oestrogen receptor contains a mutation which alters its hormone binding properties. EMBO J 8: 1981-1986, 1989
51. Faaland CA, Thomas TJ, Watkins LF, Thomas T: Estrogenic stimulation of ornithine decarboxylase (ODC) in MCF-10A breast epithelial cells transfected with estrogen receptor (ER) gene. Proc Am Assoc Cancer Res 35: 260, 1994
52. Shiu RP: Processing of prolactin by human breast cancer cells in king-term tissue culture. J Biol Chem 255: 4278-4281, 1980
53. Lamps SJ, Findlay DM, Moseley JM, Martin TJ: Calcitonin induction of a persistent activated state of adenylate cyclase in human breast cancer cells (T-47D). J Biol Chem 256: 12269-12274, 1981
54. Keydar I, Chen L, Karby S, Weiss FR, Delarea J, Radu M, Chaitcik S, Brenner HJ: Establishment and characterization of a cell line of human breast carcinoma origin. Eur J Cancer 15: 659-670, 1979
55. Jiang SY, Wolf DM, Yingling JM, Chang C, Jordan VC: An estrogen receptor positive MCF-7 clone that is resistant to antiestrogens and estradiol. Mol Cell Endocrinol 90: 77-86, 1992
56. Hackett AJ, Smith HS, Springer EL, Owens RB, Nelson-Rees WA, Riggs JL, Gardner MB: Two syngeneic cell lines from human breast tissue: the aneuploid mammary epithelial (Hs578T) and the diploid myoepithelial (Hs578 Bst) cell lines. J Natl Cancer Inst 58: 1795-1806, 1977
57. Cailleau R, Young R, Olive M, Reeves WJ Jr: Breast tumor cell lines from pleural effusions. J Natl Cancer Inst 53: 661-674, 1974
58. Faaland CA, Laskin JD, Thomas TJ: Inhibition of epidermal growth factor-stimulated EGF receptor tyrosine kinase activity in A431 human epidermoid carcinoma cells by polyamines. Cell Growth Different 6: 115-121, 1995
59. Wakeling AE, Dukes M, Bowler J: A potent specific pure antiestrogen with clinical potential. Cancer Res 51: 3867-3873, 1991
60. McDonnell DP, Vegeto E, O'Malley BW: Identification of a negative regulatory function for steroid receptors. Proc Natl Acad Sci USA 89: 10563-10567, 1992
61. Kipl, a cyclin-Cdk inhibitor, links transforming growth factor β and contact inhibition to cell cycle arrest. Genes Dev 8: 9-22, 1994
62. Toyoshima H, Hunter T: p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78: 67-74, 1994
63. 1NK4B is a potential effector of the TGF-β-induced cell cycle arrest. Nature 371: 257-261, 1994
64. Slingerland JM, Hengst L, Pan CH, Alexander D, Stampfer MR, Reed SI: A novel inhibitor of cyclin-Cdk activity directed in transforming growth factor β-arrested epithelial cells. Mol Cell Biol 14: 3683-3694, 1994
65. Hengst L, Dulic V, Slingerland JM, Lees E, Reed SI: A cell cycle-regulated inhibitor of cvclin-dependent kinases. Proc Natl Acad Sci USA 91: 5291-5295, 1994
66. Jiang A, Thomas TJ, Faaland CA, Thomas T: Epidermal growth factor (EGF) stimulates the expression of p21 (CIP1/ WAF1) cyclin dependent kinase (CDK) inhibitor in MDA-MB-468 breast cancer cells. Proc Am Assoc Cancer Res 36: 580, 1995
67. Sysounthone V, Thomas T, Shah N, Faaland CA, Thomas TJ: Inactivation of the cell cycle inhibitory protein, p21 (CIP1/ WAF1) during chemical carcinogenesis of normal breast epithelial cells. Proc Am Assoc Cancer Res 36: 580, 1995
68. Onate SA, Tsai SY, Tsai M-J, O'Malley BW: Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270: 1354-1357, 1995
69. Klein-Hitpass L, Ryffel GU, Heitlinger E, Cato ACB: A 13 bp palindrome is a functional estrogen responsive element and interacts specifically with estrogen receptor. Nucl Acids Res 16: 647-663, 1988
70. Dana SL, Hoener PA, Wheeler DA, Lawrence CB, McDonnell DP: Novel estrogen response elements identified by genetic selection in yeast are differentially responsive to estrogens and anti-estrogens in mammalian cells. Mol Endocrinol 8: 1193-1207, 1994
71. Kraus WL, Montano MM, Katzenellenbogen BS: Identification of multiple, widely spaced estrogen-responsive regions of the rat progesterone receptor gene. Mol Endocrinol 8: 952-969, 1994
72. Smith CL, Conneely OM, O'Malley BW: Modulation of the ligand-independent activation of the human estrogen receptor by hormone and antihormone. Proc Natl Acad Sci USA 90: 6120-6124, 1993
73. Shiohara M, El-Deiry WS, Wada M, Nakamaki T, Takeuchi S, Yang R, Chen DL, Vogelstein B: Absence of WAF1 mutations in a variety of human malignancies. Blood 84: 3781-3784, 1994
74. Landel CC, Kushner PJ, Greene GL: The interaction of human estrogen receptor with DNA is modulated by receptor-associated proteins. Mol Endocrinol 8: 1407-1419, 1994
75. Halachmi S, Marden E, Martin G, MacKay H, Abbondanza C, Brown M: Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription. Science 264: 1455-1458, 1994